Clinical Trial Update: Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety trial evaluating ChAdOx1 85A vaccination with and without an MVA85A boost in healthy adults has been completed. The trial was sponsored by the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ChAdOx1 85A (ChAdOx1 85A)
• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED